The Montgomery Breast Center of Montgomery, Ala., became the first center in the U.S. to install and use the GammaLoc lesion-localization system, an FDA-cleared device that allows gamma-guided, minimally invasive needle biopsy of suspicious lesions identified with breast-specific gamma imaging.

Breast-specific gamma imaging is performed by the Dilon 6800, a gamma camera that reveals lesions independent of tissue density for detection of early-stage cancers that are often not identified with other imaging methods, such as mammography, ultrasound and MRI, said Dilon.

The entire GammaLoc system is portable, allowing physicians to perform molecular imaging-guided biopsy procedures anywhere on site, added Newport News, Va.-based company.